ARA 290 (Cibinetide) Overview
ARA 290 is a next-generation peptide derived from erythropoietin (EPO), designed to provide anti-inflammatory, neuroprotective, and tissue-healing support without stimulating excess red blood cell production.
Peptide Profile
- Name: ARA 290 (Cibinetide)
- CAS Number: 1208243-50-8
- Molecular Formula: C51H84N16O21
- Main Function: Anti-inflammatory, neuroprotective, tissue-regenerative peptide
- Mechanism: Engages the erythropoietin/CD131 “innate repair receptor” (IRR) to activate protective and regenerative pathways without driving erythropoiesis
Key Benefits
- Reduces neuropathic pain and nerve sensitivity
- Supports nerve regeneration and function
- Calms systemic inflammation and protects tissues
- Promotes wound healing and recovery after stress or training
- Supports kidney, cardiovascular, and metabolic health
- May enhance endurance recovery and overall performance
- Generally well-tolerated with a favorable safety profile
Research & Applications
- Human studies show improvements in small-fiber neuropathy and sarcoidosis-related symptoms
- Reduces pain scores and improves physical functioning and wellbeing
- Supports tissue protection, metabolic balance, and nerve health
- Applications in sports: accelerated recovery, joint and tendon comfort, neural support during high-volume training
Possible Side Effects
- Mild injection-site discomfort
- Rare, temporary changes in blood pressure or blood sugar
- Very rare allergic responses (rash, swelling, or breathing difficulty)
Note: Informational content only.